A Futuristic Synthesis Indeed
Merck has published a paper detailing the industrial synthesis of enlicitide, a complex macrocyclic peptide. The molecule is noted for its significant commercial potential due to its challenging synthesis. Previous attempts by other companies to create a small-molecule version for oral dosing have not succeeded.
- ▪Merck's recent paper focuses on the industrial synthesis of enlicitide.
- ▪Enlicitide is described as a highly active macrocyclic peptide.
- ▪The complexity of its structure suggests that large-scale production will be difficult.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4905632-futuristic-synthesis-indeed"},"author":{"@type":"Person","name":"Derek Lowe","url":"https://seekingalpha.com/author/derek-lowe"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
